Testosterone treatment therapy, which has become to treat a wide range of ailments among aging men, has been linked to a significantly heightened risk for heart attack, stroke, and serious cardiac events. Thousands of testosterone lawsuits, aimed at holding drug companies accountable for the harm their products have caused, are pending in U.S. District Court. Men and the families of men who have suffered from heart attack, stroke, or a serious cardiac problem while taking testosterone replacement therapy say they were not adequately warned of the risk posed by these supplemental drugs.
Critics of testosterone replacement therapy say the substance has been treated casually, being widely prescribed to men who complain of a variety of maladies that are normal aspects of aging such as decreased energy, lowered strength, weight gain and decreased libido. In fact, testosterone replacement therapy has only been approved by the FDA to treat hypogonadism, a medical condition characterized by a lack of serum testosterone in the body that can cause a number of health problems. Hypogonadism is diagnosed with a blood test; endocrinologists say that men who are taking testosterone who have not been diagnosed with true hypogonadism are being exposed to serious heart risks unnecessarily. Furthermore, experts point out that testosterone supplementation has not been shown to be effective for treating ordinary complaints of aging that are not associated with a medical diagnosis.
More than ten companies are included among the defendants in testosterone lawsuits currently pending. Among the charges against these companies is an accusation of false adverting. Through launching aggressive marketing campaigns aimed at raising awareness of a fabricated disease coined "Low-T", critics say these companies have encouraged men to self-diagnose a need for testosterone supplementation. More men than ever before are now taking testosterone replacement therapy, through pills, injections, patches, gels and other means. Total sales of testosterone boosting drugs exceeded $2 billion in 2012, and are projected to reach $5 billion by 2017. Among the most popular of these drugs are Testim, Androgel, Androderm, and Axiron.
Research shows that men undergoing testosterone replacement therapy face a risk of heart attack, stroke, and other cardiac problems that is two- to three-times higher than without the drug. Very few men were aware of the dangers of testosterone replacement therapy when they chose to use the substance. Marketing for these drugs suggested the treatment was harmless and could be used by almost anyone. In January of 2014, an FDA testosterone warning was released, announcing the launch of an investigation into the safety and efficacy of the substance. Drug companies are now subject to new regulations which control their marketing practices for testosterone replacement therapy. The FDA Testosterone warning cited studies published in the Journal of the American Medical Association (JAMA) as well as in the online journal PLOS ONE, citing evidence that testosterone replacement therapy increases the risk of stroke, heart attack, and other cardiac problems.
Men and the family members of men who suffered stroke, heart attack, or another serious cardiac event while taking testosterone replacement therapy may be eligible to compensation for the medical expenses, suffering, damages, and loss they have sustained by filing a testosterone lawsuit. Testosterone lawsuits aim to hold pharmaceutical companies accountable for predatory marketing campaigns that presented testosterone replacement therapy as a safe option for aging men, understating the risk of serious side effects. Men and the family members of men who have suffered from health problems while taking testosterone supplementing drugs may be entitled to compensation.
Attorneys handling testosterone lawsuits are now accepting claims from men and the family members of men who have suffered severe health conditions such as stroke, heart attack and other cardiac problem while undergoing testosterone replacement therapy. These individuals may be entitled to compensation for the damages, expenses and loss they have suffered as a result of taking drugs such as Androgel, Testim, and many others. The Onder Law Firm will represent all persons involved in a testosterone heart attack lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. For a free no-obligation consultation please complete the brief online contact form or call us at 1-800-799-2824 and one of our attorneys handling national* testosterone lawsuits will contact you to answer any of your questions.
A leader in cancer research at Harvard University asserts that perhaps 10,000 cases of ovarian cancer can be blamed each year on perineal talc use in the US. Despite the existence of evidence that talc-based products are dangerous and can cause cancer, talc is not regulated in the US. The American Cancer Society estimates that in 2013, about 22,240 new cases of ovarian cancer will be diagnosed, while 14,030 women will die as a result of ovarian cancer in the US.
Roundup weed killer, manufactured by Monsanto, uses a chemical called glyphosate, which the World Health Organization labeled as a probable carcinogen in 2015. Roundup is the most popular of all glyphosate-based herbicides. As little as 8 hours of Roundup exposure has been linked to an increased risk of non-Hodgkin lymphoma, multiple myeloma, and leukemia. Millions of gardeners, landscapers, farmers and others have been exposed to Roundup cancer risks.
Physiomesh is a form of surgical mesh that has been used in hernia repair surgeries. Ethicon Physiomesh was used in ventral hernia repair and has been pulled from the market due to a high failure rate. Persons with Ethicon Physiomesh have experienced an array of complications that include pain, infection, hernia recurrence, adhesion or scar-tissue buildup, intestinal blockage, bleeding, perforation, organ damage, and the need for revision surgery.